Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Wealth building strategies for young adults are essential. Discover ways to grow your wealth and achieve financial goals.
15,651 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A growing cohort of retirees is turning to a 3.56% yield strategy as grocery bills rise. The Invesco DBA ETF provides...
Many retirees are surprised to learn that part of their social security benefit can be taxed. This guide explains how...
A long-standing tax rule on Social Security benefits that was never inflation-indexed is now catching more middle-cla...
Two major price cuts from Chinese AI labs are changing the economics of frontier AI. For crypto traders and funds, ch...
Traders are turning to a wheel-style IBIT options strategy that converts Bitcoin's volatility into premium. The appro...
Salesforce leans on a sweeping buyback to defend its core, while ServiceNow expands through acquisitions focused on s...
If you own a short-term rental, smart tax planning can save thousands. This guide shows practical steps to maximize d...
If you plan to start Social Security at 62 while still working, your benefits may be reduced. This guide walks throug...
A conflict over Iran threatens Asia's access to fertilizer and helium, risking farm yields and semiconductor supply c...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
A hypothetical 62-year-old retiree’s $2.4m portfolio could decline sharply if negative years hit early, underscoring ...